Peptide-Based Biosensors

Peptides serve as versatile recognition elements in biosensor platforms owing to their high binding specificity, chemical tunability, and amenability to solid-phase synthesis. Peptide-based biosensors integrate transducer technologies with peptide ligands to enable real-time detection of biomarkers, pathogens, and small-molecule analytes.

Aptamer-Integrated Systems

Peptide nucleic acid (PNA) aptamers combine the structural flexibility of peptides with the sequence-specific recognition of nucleic acids. Unlike DNA or RNA aptamers, PNA aptamers resist nuclease degradation while maintaining high-affinity target binding. When coupled with electrochemical transducers, PNA aptamers detect target proteins at femtomolar concentrations. Conformational changes upon target binding alter electron transfer kinetics, generating measurable impedance or voltammetric signals.

Molecular Imprinted Polymers

Molecular imprinted polymers (MIPs) containing peptide templates create synthetic recognition cavities that mimic antibody binding sites. The imprinting process involves polymerizing functional monomers around a target peptide, then removing the template to leave complementary cavities. MIP-based sensors demonstrate binding affinities comparable to monoclonal antibodies while offering superior thermal stability and reusability. Electrochemical MIP sensors incorporating conducting polymers such as polyaniline achieve detection limits in the picomolar range.

Lateral Flow Assays

Peptide-based lateral flow assays provide rapid point-of-care diagnostic capabilities. Peptides immobilized on nitrocellulose membranes capture target analytes from complex biological samples, with gold nanoparticle-conjugated secondary recognition elements generating visible signal lines. Compared to antibody-based lateral flow assays, peptide-based versions offer reduced manufacturing costs, batch consistency, and room-temperature storage stability.

Electrochemical Platforms

Peptide-modified electrodes exploit binding-induced changes in surface charge, conductivity, or electron transfer rates to quantify analyte concentrations. Cyclic voltammetry, differential pulse voltammetry, and electrochemical impedance spectroscopy serve as detection modalities. Peptide-modified field-effect transistors provide label-free, real-time monitoring of binding events.

Multiplexed Detection

Array-based peptide biosensors enable simultaneous detection of multiple analytes from a single sample. Spatial resolution of binding events across peptide-functionalized microarrays permits comprehensive biomarker profiling. Integration with smartphone-based readers democratizes access to sophisticated diagnostic capabilities.

Clinical Applications

Peptide biosensors are being developed for cardiac biomarker detection, cancer screening, infectious disease diagnostics, and environmental monitoring. Regulatory pathways for peptide-based diagnostic devices continue to evolve alongside technological maturation.